Virax Biolabs Group Ltd (VRAX)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Jun 28, 16:00
1.15
-0.01
(-0.86%)
After-Hours: 20:00
Virax Biolabs Group Debt to Equity Ratio: 0.00 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| March 31, 2023 | 0.016 |
| September 30, 2022 | 0.0888 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| September 30, 2021 | -0.1252 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1252
Minimum
Sep 2021
0.0888
Maximum
Sep 2022
-0.0034
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.025M |
| Total Liabilities (Quarterly) | 0.919M |
| Shareholders Equity (Quarterly) | 6.333M |
| Current Ratio | 7.587 |